62550 Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Medical Genetics 

Working Group. 

Date: November 10, 2010. 

Time: 1 p.m. to 5 p.m. 

Agenda: Programmatic and policy needs 

and opportunities related to NCBI 

information resources in the medical genetics 

area. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: David J. Lipman, MD, 

Director, National Center for Biotechnology 

Information, National Library of Medicine, 

Department of Health and Human Services, 

Building 38A, Room 8N805, Bethesda, MD 

20892, 301–435–5985, 

dlipman@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS). 

Dated: October 5, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–25626 Filed 10–8–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Meeting of a Subcommittee of the 

National Advisory Council for 

Healthcare Research and Quality 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Notice of public meeting. 

SUMMARY: In accordance with section 

10(a) of the Federal Advisory Committee 

Act, 5 U.S.C. App. 2, this notice 

announces a meeting of a Subcommittee 

of the National Advisory Council for 

Healthcare Research and Quality. 

DATES: The meeting will be held on 

Monday, October 18th from 10 a.m. to 

6 p.m., and Tuesday, October from 9 

a.m. to 3 p.m. 

ADDRESSES: The meeting will be held at 

the Westin Washington DC City Center, 

1400 M Street, NW., Washington, DC. 

FOR FURTHER INFORMATION CONTACT: 

Nancy Wilson, MD MPH, Coordinator of 

the Advisory Council Subcommittee, at 

the Agency for Healthcare Research and 

Quality, 540 Gaither Road, Rockville, 

Maryland, 20850, (301) 427–1310. For 

press-related information, please contact 

Karen Migdail at (301) 427–1855. 

If sign language interpretation or other 

reasonable accommodation for a 

disability is needed, please contact the 

Food and Drug Administration (FDA) 

Office of Equal Employment 

Opportunity and Diversity Management 

on (301) 827–4840, no later than 

October 11 2010. The agenda, roster, 

and minutes will be available from Dr. 

Nancy Wilson. 

SUPPLEMENTARY INFORMATION: 

I. Purpose of the Sub-Committee 

The purpose of the Sub-Committee is 

to advise AHRQ and the Centers for 

Medicare Medicaid Services (CMS) 

about measures that could be used to 

monitor the quality of care for Medicaid 

eligible adults. 

Section 2701 of the Affordable Care 

Act (ACA) requires the Secretary of 

Health and Human Services to identify 

and publish a recommended core set of 

adult health quality measures for 

Medicaid eligible adults. ACA also 

requires the Secretary, in consultation 

with States, to develop a standardized 

format for reporting information and to 

develop procedures that encourage 

voluntary reporting based on the initial 

core set of measures. The Secretary is 

also required to establish a Medicaid 

Quality Measurement Program that will 

fund the development, testing, and 

validation of emerging and innovative 

evidence-based measures and to 

subsequently publish recommended 

changes to the initial core measure set. 

Not later than September 30, 2014 and 

annually thereafter the Secretary is 

required to collect, analyze, and make 

publically available the information 

reported by the States. 

AHRQ is working collaboratively with 

CMS to identify and publish for public 

comment an initial preliminary core set 

of measures by January 1, 2011. The 

initial core set of measures must then be 

finalized by January 1, 2012. 

The purpose of the National Advisory 

Council Sub-Committee is to: (a) 

Evaluate measures on importance, 

validity, and feasibility for use by 

Medicaid programs (b) apply criteria to 

identify compilations of measures that 

could be selected for the initial core 

measurement set. The Sub-Committee 

membership will reflect expertise in 

healthcare quality measurement, 

healthcare disparities, and in the 

populations eligible for Medicaid. 

Elizabeth McGlynn, PhD, Associate 

Director for RAND Health, and Foster 

Gesten, M.D., Medical Director of Office 

of Insurance Programs for New York, 

have agreed to co-chair the SubCommittee. 

II. Purpose of the National Advisory 

Council 

The National Advisory Council for 

Healthcare Research and Quality was 

established in accordance with Section 

921 (now Section 941) of the Public 

Health Service Act, 42 U.S.C. 299c. In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director, Agency for 

Healthcare Research and Quality 

(AHRQ), on matters related to AHRQ’s 

conduct of its mission including 

providing guidance on (A) priorities for 

health care research, (B) the field of 

health care research including training 

needs and information dissemination on 

health care quality and (C) the role of 

the Agency in light of private sector 

activity and opportunities for public 

private partnerships. 

Role of the National Advisory Council 

The National Advisory Council for 

Healthcare Research arid Quality was 

established in accordance with Section 

921 (now Section 941) of the Public 

Health Service Act, 42 U.S.C. 299c. In 

accordance with its statutory mandate, 

the Council is to advise the Secretary of 

the Department of Health and Human 

Services and the Director, Agency for 

Healthcare Research and Quality 

(AHRQ), on matters related to AHRQ’s 

conduct of its mission including 

providing guidance on (A) priorities for 

health care research, (B) the field of 

health care research including training 

needs and information dissemination on 

health care quality and (C) the role of 

the Agency in light of private sector 

activity and opportunities for public 

private partnerships. 

The Council is composed of members 

of the public, appointed by the 

Secretary, and Federal ex-officio 

members specified in the authorizing 

legislation. 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices 62551 

III. Agenda 

The final agenda will be available on 

the AHRQ Web site at www.AHRQ.gov 

no later than October 12, 2010. 

This notice is published less than 15 

days in advance of the meeting date due 

to logistical difficulties. 

Dated: September 30, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–25224 Filed 10–8–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

November 19, 2010, 8 a.m. to November 

19, 2010, 6 p.m., Embassy Suites at the 

Chevy Chase Pavilion, 4300 Military 

Road, NW., Washington, DC, 20015 

which was published in the Federal 

Register on September 30, 2010, 75 FR 

60465–60466. 

The meeting will be held at the 

Embassy Suites Washington DC, 1250 

22nd Street, NW., Washington, DC 

20030. The meeting date and time 

remain the same. The meeting is closed 

to the public. 

Dated: October 5, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–25601 Filed 10–8–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel, 

October 27, 2010, 2:30 p.m. to October 

27, 2010, 5:30 p.m., National Institutes 

of Health, 6701 Rockledge Drive, 

Bethesda, MD, 20892 which was 

published in the Federal Register on 

September 30, 2010, 75 FR 60465– 

60466. 

The meeting has been changed to an 

Internet Assisted Meeting (IAM). The 

meeting will be two days October 27, 

2010, from 8 a.m. to October 28, 2010, 

6 p.m. The meeting is closed to the 

public. 

Dated: October 4, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–25598 Filed 10–8–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Nucleic Acid Biology. 

Date: October 26, 2010. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Barbara Whitmarsh, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2206, 

MSC 7890, Bethesda, MD 20892, (301) 357– 

5556, whitmarshb@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: NeuroAIDS and Other End-Organ 

Diseases. 

Date: October 28, 2010. 

Time: 3:15 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Eduardo A. Montalvo, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7852, Bethesda, MD 20892, (301) 435– 

1168, montalve@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Social Sciences and Population 

Studies. 

Date: November 1, 2010. 

Time: 11:30 a.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Valerie Durrant, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3148, 

MSC 7770, Bethesda, MD 20892, (301) 408– 

9882, durrantv@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Biobehavioral Mechanisms of 

Emotion, Stress and Health. 

Date: November 3, 2010. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Melissa Gerald, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3172, 

MSC 7848, Bethesda, MD 20892, (301) 408– 

9107, geraldmel@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR10–074: 

Program Project: Methods in Crystallization. 

Date: November 4–5, 2010. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: David R. Jollie, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4150, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

1722, jollieda@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR08–259: 

Program Project: Fluorescence Spectroscopy 

Resource. 

Date: November 8–10, 2010. 

Time: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Atrium Hotel, 18700 MacArthur 

Boulevard, Irvine, CA 92612. 

Contact Person: Arnold Revzin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4146, 

MSC 7806, Bethesda, MD 20892, (301) 435– 

1153, revzina@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR–08– 

222: International Brain Disorders. 

Date: November 18, 2010. 

Time: 8:30 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: US Grant Hotel, 326 Broadway, San 

Diego, CA 92101. 

Contact Person: Dan D. Gerendasy, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3218, 


srobinson on DSKHWCL6B1PROD with NOTICES